Cerebrospinal Fluid (CSF) Management Market to Reach USD 2.2 Billion By 2027
The rising incidence of hydrocephalus and other brain disorders is stimulating Cerebrospinal Fluid (CSF) Management industry growth.
Market Size – USD 1.51 billion in 2019, Market Growth – CAGR of 4.7%, Market Trends – rise in shunting procedures and high R&D investment in the field of cerebrospinal fluid management.
According to a new report by Reports and Data, the Cerebrospinal Fluid (CSF) Management market size is forecast to reach USD 2.2 billion in terms of annual remunerations from USD 1.51 Billion in 2019, delivering a CAGR of 4.7% through 2027. The market growth is driven by the growing prevalence of hydrocephalus and subsequent demand for a number of shunting procedures.
There is a significant shortage of neurophysicists and neurosurgeons across the world. The current number of neurosurgeons is insufficient to meet the demand for health care. This is prompting high investment in research & development in the field of cerebrospinal fluid management and treatment. Several research projects are underway and are aimed at the management of hydrocephalus and other disorders associated with cerebrospinal fluid.
A significant rise in the number of people suffering from hydrocephalus and other brain disorders is poised to boost market revenue share. Moreover, growing awareness regarding the diagnosis and treatment of cerebrospinal fluid disorders will foster Cerebrospinal Fluid (CSF) Management market size over the forecast period.
To read the full report now, with industry-wide coverage, visit:
https://www.reportsanddata.com/report-detail/cerebrospinal-fluid-csf-management-market
Further key findings from the report suggest
- On the basis of type, the shunts segment is forecast to register a CAGR of 7.2%, generating revenue close to USD 1065.1 Million through 2027. The increasing number of revision shunt surgeries is positively impacting cerebrospinal fluid drainage device market growth.
- Based on end-use, the hospitals segment is expected to grow at a CAGR of 5.4%, with a revenue share of USD 781.5 Million by 2027 on account of a rise in number of in-hospital cases related to cerebrospinal fluid management in the geriatric population.
- The Ambulatory Surgical Centers & Diagnostic Centers segment is anticipated to witness a notable growth rate of 6.1% over the analysis period due to low-cost surgery in these facilities.
- Based on patient type, the pediatric segment is estimated to account for USD 663.6 Million, delivering a CAGR of 5.8% through 2027. The robust growth can be attributed to the growing prevalence of congenital hydrocephalus, primarily in the pediatric population, along with associated demand for shunting procedures.
- In the regional landscape, the APAC region is expected to garner USD 634.7 Million in the cerebrospinal fluid management devices market share, at a CAGR of 6.6% through 2027. Presence of a huge patient pool in the developing economies coupled with rising healthcare spending is offering lucrative scope for the CSF management market growth.
- North America contributed to a revenue share of USD 590.25 Million in 2019 and is forecast to register a growth rate of 4.6% through 2027. The growth can be attributed to a huge patient base with nervous disorders and a rise in new product approvals by the U.S. FDA for cerebrospinal fluid management.
- Prominent players in the market are Sophysa (France), Dispomedica (Germany), Spiegelberg GmbH (Germany), Integra LifeSciences (US), Medtronic plc (Ireland), B. Braun (Germany), Sophysa (France|), Argi Grup (Turkey), DePuy Synthes (US), and Moller Medical (Germany), among others.
Segments covered in the report:
For the purpose of this study, Reports and Data has segmented the Cerebrospinal Fluid (CSF) Management Market on the basis of types, end-use, patient type, and regional analysis.
Types (Revenue, USD Million; 2017-2027)
- Shunts
- Ventriculoperitoneal Shunts
- Ventriculoatrial Shunts
- Lumboperitoneal Shunts
- Ventriculopleural Shunts
- Fixed Valve Shunts
- Adjustable Valve Shunts
- External Drainage Systems
- External Ventricular Drainage Systems
- Lumbar Drainage Systems
End Use (Revenue, USD Million; 2017-2027)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Patient Type (Revenue, USD Million; 2017-2027)
- Pediatric
- Adult
- Geriatric
Region (Thousand, Units and Revenue, USD Million; 2017-2027)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more, and our team will ensure the report is well suited to meet your requirements.
